Journal profile

Journal of diabetes science and technology

Publisher: Sage
ISSN1932-2968 | 1932-3107 FormatOnline StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.88
Citation rate 4.09 1,597 total citations
h5-index 43 h5 depth signal
Cited share 81.0% 325 of 401
Total citations 1,597 Citation footprint
Metric signal 4.34 External metric anchor
Self-citation 10.6% 169 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 1,149
Germany 372
United Kingdom 227
Denmark 125
Italy 114

Citing Fields of Research

Diabetes 1,879
Clinical Laboratory Science 211
Health Education & Remote Healthcare 160
Nutrition & Dietetics 82
Wounds & Ulcers 82

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 3,988 Articles tracked across the journal lifetime
Indexed publication set 401 325 cited publications
Last 12 months 201 16.8 publications/month
Open access share 20.9% 42 OA publications in the last year
Leading citing country United States 1,149 citing publications
Leading citing field Diabetes 1,879 citing publications
Latest tracked publication 18 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v3n1, 2009-
PubMed
v1, 2007-
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Diabetes

Issuing & Sponsoring Bodies

Contributor
Diabetes Technology Society

Broad Categories

Endocrinology Diabetes

MeSH Descriptors

Diabetes Mellitus

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Elena D. Georges, Neha Parimi, Karen Dimentstein et al.
Introduction: The American Diabetes Association recommends screening for diabetes distress in individuals with diabetes and their caregivers. We evaluated the clinical utility of the Problem Areas in Diabetes–Parent Revised version (PAID...
02
Reem Alamoudi, Ali Alqarni, Maram Alsubaiee et al.
Objective: The effect of basal insulin timing on hypoglycemia during Ramadan fasting remains uncertain despite recommendations to administer basal insulin earlier in the evening. We evaluated whether early evening compared with bedtime a...
03
Mohammadreza Ganji, Benjamin Lobo, Anas El Fathi et al.
Background: The glycemia risk index (GRI) is a validated continuous glucose monitoring (CGM)-derived metric of overall glycemic risk. Hemoglobin A1c (HbA1c) has been the gold-standard metric of glycemic control since the Diabetes Control...
05
Benjamin Lalani, Shiv S. Patel, Ihewa Gaula et al.
Insulin pumps are durable, high-cost medical devices that support continuous subcutaneous insulin infusion and automated insulin delivery. Despite their utility, access to insulin pumps in the United States remains uneven across socioeco...
06
Ayman Al Hayek, Wael M. Al Zahrani, Haifa F. Alotaibi et al.
Background: The effectiveness of continuous glucose monitoring (CGM) in adults with type 2 diabetes (T2D) not receiving intensive insulin therapy remains incompletely established, particularly regarding glycemic metrics beyond glycated h...

Bibliographical & Catalog Notes

Description based on: Vol. 1, issue 1 (Jan. 2007); title from HTML header (publisher's Web site viewed Nov. 13, 2009).

Latest issue consulted: Vol. 3, issue 6 (Nov. 2009) (publisher's Web site viewed Nov. 13, 2009).

Also issued online.

Mode of access: World Wide Web.